↓ Skip to main content

Long-term effectiveness of carglumic acid in patients with propionic acidemia (PA) and methylmalonic acidemia (MMA): a randomized clinical trial

Overview of attention for article published in Orphanet Journal of Rare Diseases, October 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Long-term effectiveness of carglumic acid in patients with propionic acidemia (PA) and methylmalonic acidemia (MMA): a randomized clinical trial
Published in
Orphanet Journal of Rare Diseases, October 2021
DOI 10.1186/s13023-021-02032-8
Pubmed ID
Authors

Majid Alfadhel, Marwan Nashabat, Mohammed Saleh, Mohammed Elamin, Ahmed Alfares, Ali Al Othaim, Muhammad Umair, Hind Ahmed, Faroug Ababneh, Fuad Al Mutairi, Wafaa Eyaid, Abdulrahman Alswaid, Lina Alohali, Eissa Faqeih, Mohammed Almannai, Majed Aljeraisy, Bayan Albdah, Mohamed A. Hussein, Zuhair Rahbeeni, Ali Alasmari

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 12%
Student > Ph. D. Student 1 6%
Unspecified 1 6%
Professor > Associate Professor 1 6%
Student > Doctoral Student 1 6%
Other 0 0%
Unknown 11 65%
Readers by discipline Count As %
Medicine and Dentistry 2 12%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Unspecified 1 6%
Chemistry 1 6%
Biochemistry, Genetics and Molecular Biology 1 6%
Other 0 0%
Unknown 11 65%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 December 2021.
All research outputs
#15,985,273
of 25,732,188 outputs
Outputs from Orphanet Journal of Rare Diseases
#1,721
of 3,179 outputs
Outputs of similar age
#223,263
of 440,389 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#59
of 122 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,179 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one is in the 44th percentile – i.e., 44% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,389 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 122 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.